UNSPSC 51411902: Droprenilamine

This classification denotes a vasodilating agent with the molecular formula C24H33N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 31IPX0ZD7R, chemically known as (+-)-n-(3,3-diphenylpropyl)-alpha-methylcyclohexaneethylamine but generally known as droprenilamine, which bears US NIH Compound Identifier 65470. European Medicines Agency schedules Droprenilamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06411MIG.

UNSPSC 51411902 Droprenilamine, a Commodity code, covers prescription medications and pharmaceutical products that state and local governments procure for emergency medical services, public health programs, and institutional healthcare operations. Recent solicitations show state and local buyers purchasing specific advanced life support medications, generic multi-source pharmaceuticals, and over-the-counter products through competitive bidding and cooperative purchasing arrangements. The issuing bodies span city purchasing departments managing emergency medical services supply chains, state health and human services commissions evaluating pharmacy benefit program strategies, and multistate cooperative purchasing alliances coordinating procurement across participating jurisdictions. The code reflects actual procurement of named pharmaceutical line items — epinephrine, labetalol, adenosine, diltiazem, and generic multi-source drugs — rather than abstract pharmaceutical categories, with vendors required to meet FDA compliance, Good Manufacturing Practices certification, Drug Supply Chain Security Act compliance, and OSHA hazard communication standards.

Geographic activity concentrates in Florida, Texas, and Minnesota, with the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) serving multiple states including Oregon. The City of Tampa's Purchasing Department issued an IFB for Advanced Life Support Medications (Solicitation 26P00188) with a due date of April 8, 2026, requiring delivery of 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials to Tampa Fire Rescue, with an estimated contract value of $40,000.00 and a one-year term plus optional renewals. The Minnesota Department of Administration issued an RFP through MMCAP (Solicitation S1070000015802) for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026, requiring vendors to supply through three authorized wholesalers and maintain compliance with cGMP and DSCSA, with a two-year contract term effective July 1, 2026. The Texas Health and Human Services Commission posted an RFI (HHS0017013) in April 2026 to gather market intelligence on direct-to-manufacturer prescription program capabilities, signaling exploratory procurement strategy development prior to formal competitive solicitation.